Uncategorized

Bayer to make ‘careful but aggressive’ return to pharma M&A, CEO says

Published

1 month ago

on

May 12, 2026

By

Temp User

Bayer is back on the market for drug acquisitions after a half-decade on the sidelines, according to CEO Bill Anderson.

“We’re going to be careful, but also aggressive,” Anderson said on a first-quarter earnings call …

Related Topics:

Leave a Reply

Uncategorized9 years ago

These ’90s fashion trends are making a comeback in 2017
Uncategorized9 years ago

According to Dior Couture, this taboo fashion accessory is back
Endpoints News3 months ago

Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
Uncategorized9 years ago

Phillies’ Aaron Altherr makes mind-boggling barehanded play
Uncategorized9 years ago

Uber and Lyft are finally available in all of New York State
Contributors9 years ago

The final 6 ‘Game of Thrones’ episodes might feel like a full season

Exit mobile version